Warning letters, 483s, Recalls, Import Alerts, Audit observations
In December 2024, the Indian drug regulator, CDSCO, flagged 51 drugs as Not of Standard
The Indian drug regulator, CDSCO, has published a list of spurious drugs detected in November
The Central Drugs Standard Control Organization (CDSCO) has issued a spurious drug alert for popular
In September 2024, the European Commission (EC) revoked the Conditional Marketing Authorisation (CMA) for Advanz
USFDA is proposing to remove oral phenylephrine as an active ingredient in over-the-counter (OTC) drug
CDSCO has published an update on the Spurious and Misbranded drugs in September 2024. Medicinal
CDSCO has published alert of list of drugs Not of Standard Quality (NSQ) identified during
The European Commission (EC) revoked the conditional marketing authorization (CMA) of Advanz Pharma’s Ocaliva (obeticholic
CDSCO has published a drug alert regarding voluntary recall of Tisseel Lyo Fibrin Sealant VHS/D
CDSCO has published the NSQ (Not of Standard Quality) alert for July 2024. The list
